FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/10/2022
Voltar para busca
Dado oficial do USPTO
PHARNEXT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: Estados Unidos
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
30
Atualização mais recente
10/10/2022
Tipo de marca
Mista
Classes Nice
5, 35, 42, 44
Data de depósito
01/03/2021
Data de registro
07/06/2022
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
07/06/2022
Última transação
10/06/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
FR
Examinador
PEISECKI, MARK A
Unidade examinadora
L50
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the stylized wording "PHARNEXT", with "PHAR" stacked above "NEXT", all superimposed on a shaded diamond design.
Titulares e representantes
Titulares
PHARNEXT
Representantes
Pradeep Jayaraman IpHorgan Ltd.
Classificação técnica
Classes Nice
Classe 5Classe 35Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Medicinespharmaceutical and veterinary productspharmaceutical preparations for human and veterinary usebiological preparations for medical usediagnostic products for medical usechemical preparations for medical use all for the treatment of neurologicalneurodegenerativeneuromuscular and neuropathic diseasestraumatic neuropathies and demyelinating neuropathiesautoimmune diseasescancerscardiovascular diseasesmetabolic syndromes; food supplements and nutritional supplements for medical use; dietetic food and substances in the nature of beverages adapted for medical and pharmaceutical use; homeopathic and phytotherapeutic preparationshomeopathic plant-based supplements; hygienic products for medicinedisinfectant for hygienic purposes; medicated bath preparations; dietetic beverages for medical use; chemical reagents for medical usebiomarkers; products for personal hygiene for medical purposesdisinfectant for hygienic purposes; medical plastersgauzewaddingbandages for dressings; medical dressings
Classe 35
Creationcompilation and management of databases and central data files in the field of pharmaceutical research and developmentmedicinegenetics and clinical trials; compilation of statistics in the field of health and medicine; collection and systemization of data in a central file in the field of pharmaceuticalhealth and medical research and development; public relations in the field of health and medicine
Classe 42
Development of pharmaceutical products; pharmaceutical research and development; testing on pharmaceutical products; carrying out clinical trials for pharmaceutical products; scientific research regarding medicine; bio-informaticchemical and biological analysis for scientific research purposes; research in the fields of chemistrycosmetologybiologybacteriologynutrition and biotechnology; biological and bio-informatic research services in the field of chemicalbiological and pharmaceutical products; software design and development in the field of pharmaceuticalhealth and medical research; provision of scientific research information regarding pharmaceutical products and medical and scientific research in the field of pharmaceutical products and clinical trials; scientific research on chemical reagents for medical usenamely biomarkers
Classe 44
Medical services; pharmaceutical research services; pharmaceutical adviceinformation and advisory services relating to pharmaceutical products; medical information services; provision of medical information; medical information services on the treatment of diseases
Publicações
Histórico de despachos e eventos da marca no USPTO.
30 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
21/09/2022
FIMP
FINAL DISPOSITION PROCESSED
21/09/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/09/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/06/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
07/06/2022
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
29/04/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
08/04/2022
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
01/04/2022
GPNX
NOTIFICATION PROCESSED BY IB
28/02/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15/02/2022
PUBO
PUBLISHED FOR OPPOSITION
15/02/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/02/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/02/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26/01/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/01/2022
DOCK
ASSIGNED TO EXAMINER
10/12/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/12/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/12/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/12/2021
RFNT
REFUSAL PROCESSED BY IB
23/11/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
22/10/2021
RFRR
REFUSAL PROCESSED BY MPU
22/10/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
30/09/2021
CNRT
NON-FINAL ACTION WRITTEN
29/09/2021
DOCK
ASSIGNED TO EXAMINER
23/09/2021
MAFR
APPLICATION FILING RECEIPT MAILED
10/08/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/08/2021
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
05/08/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
29/07/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PHARNEXT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.